Skip to main content

Retractable Technologies, Inc.

Product
Injection Technology
Description of Project

This contract was awarded to expand the production of the low dead-space (LDS) safety syringes and needles.

Unique Impact

LDS syringes maximize dose efficiency and allow for additional vaccinations to be obtained from vials. The utilization of LDS syringes will allow access to 20 percent more COVID-19 vaccine doses compared to non-LDS syringes.

Base Award Amount
$27,365,232.00
Category
Therapeutics Supplies and Raw Materials